CN105267230B - 一种复方芬苯达唑片剂 - Google Patents
一种复方芬苯达唑片剂 Download PDFInfo
- Publication number
- CN105267230B CN105267230B CN201510654674.8A CN201510654674A CN105267230B CN 105267230 B CN105267230 B CN 105267230B CN 201510654674 A CN201510654674 A CN 201510654674A CN 105267230 B CN105267230 B CN 105267230B
- Authority
- CN
- China
- Prior art keywords
- fenbendazole
- group
- ivermectin
- tablet
- particle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active - Reinstated
Links
- IRHZVMHXVHSMKB-UHFFFAOYSA-N fenbendazole Chemical compound [CH]1C2=NC(NC(=O)OC)=NC2=CC=C1SC1=CC=CC=C1 IRHZVMHXVHSMKB-UHFFFAOYSA-N 0.000 title claims abstract description 49
- 229960005473 fenbendazole Drugs 0.000 title claims abstract description 49
- 150000001875 compounds Chemical class 0.000 title claims abstract description 31
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 claims abstract description 26
- 229960002418 ivermectin Drugs 0.000 claims abstract description 26
- FSVJFNAIGNNGKK-UHFFFAOYSA-N 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one Chemical compound C1C(C2=CC=CC=C2CC2)N2C(=O)CN1C(=O)C1CCCCC1 FSVJFNAIGNNGKK-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229960002957 praziquantel Drugs 0.000 claims abstract description 20
- 239000000853 adhesive Substances 0.000 claims abstract description 10
- 230000001070 adhesive effect Effects 0.000 claims abstract description 10
- 239000007884 disintegrant Substances 0.000 claims abstract description 10
- 239000000945 filler Substances 0.000 claims abstract description 10
- 239000000314 lubricant Substances 0.000 claims abstract description 10
- 239000004615 ingredient Substances 0.000 claims abstract description 6
- 239000002245 particle Substances 0.000 claims description 24
- 229920000159 gelatin Polymers 0.000 claims description 21
- 235000019322 gelatine Nutrition 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 18
- 239000011812 mixed powder Substances 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 12
- 108010010803 Gelatin Proteins 0.000 claims description 11
- 239000008273 gelatin Substances 0.000 claims description 11
- 235000011852 gelatine desserts Nutrition 0.000 claims description 11
- 239000001828 Gelatine Substances 0.000 claims description 10
- 235000020985 whole grains Nutrition 0.000 claims description 10
- 239000011122 softwood Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- 238000012856 packing Methods 0.000 claims description 7
- 239000002002 slurry Substances 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 5
- 229920003023 plastic Polymers 0.000 claims description 5
- 239000004033 plastic Substances 0.000 claims description 5
- 238000002604 ultrasonography Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 229940119022 praziquantel 23 mg Drugs 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 43
- 230000000694 effects Effects 0.000 abstract description 26
- 229940079593 drug Drugs 0.000 abstract description 20
- 235000013601 eggs Nutrition 0.000 abstract description 16
- 208000015181 infectious disease Diseases 0.000 abstract description 14
- 244000045947 parasite Species 0.000 abstract description 12
- 230000002147 killing effect Effects 0.000 abstract description 7
- 230000002349 favourable effect Effects 0.000 abstract description 6
- 230000001225 therapeutic effect Effects 0.000 abstract description 6
- 230000001846 repelling effect Effects 0.000 abstract description 5
- 238000004090 dissolution Methods 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 241000282472 Canis lupus familiaris Species 0.000 description 45
- 238000012360 testing method Methods 0.000 description 30
- 238000002474 experimental method Methods 0.000 description 24
- 102000002322 Egg Proteins Human genes 0.000 description 21
- 108010000912 Egg Proteins Proteins 0.000 description 21
- 210000004681 ovum Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 19
- 238000010171 animal model Methods 0.000 description 14
- 241000242722 Cestoda Species 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 11
- 230000000507 anthelmentic effect Effects 0.000 description 10
- 229920002472 Starch Polymers 0.000 description 8
- 238000007689 inspection Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000008107 starch Substances 0.000 description 8
- 235000019698 starch Nutrition 0.000 description 8
- 108010011485 Aspartame Proteins 0.000 description 7
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 7
- 229960003438 aspartame Drugs 0.000 description 7
- 235000010357 aspartame Nutrition 0.000 description 7
- 239000000605 aspartame Substances 0.000 description 7
- 239000011259 mixed solution Substances 0.000 description 7
- 241000244203 Caenorhabditis elegans Species 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 241000282326 Felis catus Species 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 241001465677 Ancylostomatoidea Species 0.000 description 4
- 241000244206 Nematoda Species 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 244000144977 poultry Species 0.000 description 4
- 241001147672 Ancylostoma caninum Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000002141 anti-parasite Effects 0.000 description 3
- -1 benzene thibenzazoline class Chemical class 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 241000238421 Arthropoda Species 0.000 description 2
- 241000754688 Cercaria Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000464908 Elliptica Species 0.000 description 2
- HMCCXLBXIJMERM-UHFFFAOYSA-N Febantel Chemical compound C1=C(NC(NC(=O)OC)=NC(=O)OC)C(NC(=O)COC)=CC(SC=2C=CC=CC=2)=C1 HMCCXLBXIJMERM-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241000002163 Mesapamea fractilinea Species 0.000 description 2
- 208000030852 Parasitic disease Diseases 0.000 description 2
- 241000242678 Schistosoma Species 0.000 description 2
- 241000244155 Taenia Species 0.000 description 2
- 241000244030 Toxocara canis Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 239000003096 antiparasitic agent Substances 0.000 description 2
- 238000012742 biochemical analysis Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000013401 experimental design Methods 0.000 description 2
- 229960005282 febantel Drugs 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 201000002266 mite infestation Diseases 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 238000012372 quality testing Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000036387 respiratory rate Effects 0.000 description 2
- 208000004441 taeniasis Diseases 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010000351 Acariasis Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000040710 Chela Species 0.000 description 1
- 206010009344 Clonorchiasis Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 206010059410 Faecaluria Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 241000790252 Otodectes cynotis Species 0.000 description 1
- 206010034719 Personality change Diseases 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- AQXXZDYPVDOQEE-MXDQRGINSA-N Pyrantel pamoate Chemical compound CN1CCCN=C1\C=C\C1=CC=CS1.C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 AQXXZDYPVDOQEE-MXDQRGINSA-N 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000004188 Tooth Wear Diseases 0.000 description 1
- 241000242541 Trematoda Species 0.000 description 1
- 241000197881 Trichocephalus Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002609 anti-worm Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 244000079386 endoparasite Species 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 210000003194 forelimb Anatomy 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000010871 livestock manure Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 206010033794 paragonimiasis Diseases 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 229940110524 praziquantel 30 mg Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960000996 pyrantel pamoate Drugs 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510654674.8A CN105267230B (zh) | 2015-10-12 | 2015-10-12 | 一种复方芬苯达唑片剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510654674.8A CN105267230B (zh) | 2015-10-12 | 2015-10-12 | 一种复方芬苯达唑片剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105267230A CN105267230A (zh) | 2016-01-27 |
CN105267230B true CN105267230B (zh) | 2018-08-24 |
Family
ID=55137631
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510654674.8A Active - Reinstated CN105267230B (zh) | 2015-10-12 | 2015-10-12 | 一种复方芬苯达唑片剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105267230B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107753498A (zh) * | 2017-10-31 | 2018-03-06 | 佛山市雷米高动物营养保健科技有限公司 | 复方伊维菌素片剂及其制备方法 |
CN107693532A (zh) * | 2017-10-31 | 2018-02-16 | 佛山市南海东方澳龙制药有限公司 | 复方抗寄生虫制剂及其制备方法 |
CN107595871A (zh) * | 2017-10-31 | 2018-01-19 | 佛山市南海东方澳龙制药有限公司 | 含伊维菌素复方制剂及其制备方法 |
CN107837238A (zh) * | 2017-10-31 | 2018-03-27 | 佛山市南海东方澳龙制药有限公司 | 伊维菌素片剂的制备方法及伊维菌素片剂 |
CN108670974A (zh) * | 2018-06-13 | 2018-10-19 | 四川农业大学 | 一种广谱抗寄生虫咀嚼片及其制备方法 |
CN109394713A (zh) * | 2018-12-26 | 2019-03-01 | 湖北中博绿亚生物技术有限公司 | 复方芬苯达唑噻嘧啶及其制备方法 |
CN113679681A (zh) * | 2020-05-18 | 2021-11-23 | 湖北中博绿亚生物技术有限公司 | 复方芬苯达唑片剂及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101966197A (zh) * | 2010-07-26 | 2011-02-09 | 天津生机集团股份有限公司 | 用于治疗牛严重复合型寄生虫感染的组合物及制备方法 |
CN103933045A (zh) * | 2014-05-14 | 2014-07-23 | 深圳市红瑞生物科技有限公司 | 驱虫药物及其制备方法 |
-
2015
- 2015-10-12 CN CN201510654674.8A patent/CN105267230B/zh active Active - Reinstated
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101966197A (zh) * | 2010-07-26 | 2011-02-09 | 天津生机集团股份有限公司 | 用于治疗牛严重复合型寄生虫感染的组合物及制备方法 |
CN103933045A (zh) * | 2014-05-14 | 2014-07-23 | 深圳市红瑞生物科技有限公司 | 驱虫药物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105267230A (zh) | 2016-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105267230B (zh) | 一种复方芬苯达唑片剂 | |
CN105287613B (zh) | 一种复方芬苯达唑片剂的制备方法 | |
CN101773594B (zh) | 一种治疗羊腹泻的组合物及其制备方法 | |
CN100589807C (zh) | 一种复方磺胺间甲氧嘧啶钠注射液的配方及制作工艺 | |
CN103417559B (zh) | 含伊维菌素和吡喹酮的兽用复方混悬注射液及其制备方法 | |
Burke et al. | Herbal dewormer fails to control gastrointestinal nematodes in goats | |
JP2022001572A (ja) | 漢方処方菌叢カプセル、その製造方法、及び2型糖尿病の治療薬の製造における漢方処方菌叢カプセルの使用 | |
CN101111254B (zh) | 用于预防和治疗肾病的药物组合物以及含有草药提取物的保健食品 | |
CN113134008B (zh) | 宠物用伊维菌素吡喹酮咀嚼片及其制备方法 | |
CN102670694B (zh) | 一种治疗猪伪狂犬病的中药组合物及其制备方法和应用 | |
CN104435023A (zh) | 一种中药提取物及其应用 | |
CN103768157A (zh) | 一种兽用抗病毒中药紫芪泡腾颗粒药物及其制备方法 | |
CN102727596B (zh) | 一种防治鸡球虫病的中药颗粒剂及其制备方法 | |
CN109394713A (zh) | 复方芬苯达唑噻嘧啶及其制备方法 | |
CN104306388A (zh) | 一种复方伊维菌素注射剂及其制备方法 | |
CN113679681A (zh) | 复方芬苯达唑片剂及其制备方法 | |
CN101249097B (zh) | 灰树花多糖在制备防治猪病毒性疾病药物中的应用 | |
CN104606195B (zh) | 一种复方黄藤素注射液及其制备方法 | |
CN106539754A (zh) | 氢溴酸常山酮溶液及其制备方法 | |
CN102836152B (zh) | 酸浆苦素b在制备治疗和/或预防血吸虫病药物中的应用 | |
CN1660274A (zh) | 一种治疗奶牛***炎的药物组合物及其制备方法 | |
CN110448562A (zh) | 羽扇豆酮在制备治疗肾损害药物中的应用 | |
CN109498701A (zh) | 一种防治鹅副粘病毒的中药组合物及其制备方法和应用 | |
CN101045103A (zh) | 一种治疗痛风的中兽药及其制备方法和用途 | |
CN104739753A (zh) | 一种稳定的油性伊维菌素浇泼剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180824 Termination date: 20211012 |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
RR01 | Reinstatement of patent right |
Former decision: Termination of patent rights for unpaid annual fees Former decision publication date: 20220923 |
|
RR01 | Reinstatement of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240116 Address after: Building 6, Building 304A, Blue Biomedical Industry Park, No. 368 Hedong Road, High tech Zone, Qingdao, Shandong Province, 266109 Patentee after: Qingdao Deji Agricultural Biotechnology Co.,Ltd. Address before: No. 700 Changcheng Road, Chengyang District, Qingdao City, Shandong Province, 266061 Patentee before: Qingdao Agricultural University |
|
TR01 | Transfer of patent right |